Free Trial

Atria Wealth Solutions Inc. Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • Atria Wealth Solutions Inc. reduced its holdings in UnitedHealth Group by 9.5%, owning 32,375 shares valued at approximately $16.96 million as of its latest SEC filing.
  • Major institutional investors made significant changes to their positions in UnitedHealth Group in the last quarter, with some, like UBS AM, increasing their stake by 36.6%.
  • UnitedHealth Group recently increased its quarterly dividend to $2.21 per share, reflecting a boost from the previous $2.10, and representing an annualized payout of $8.84 with a yield of 3.7%.
  • Want stock alerts on UnitedHealth Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Atria Wealth Solutions Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,375 shares of the healthcare conglomerate's stock after selling 3,416 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in UnitedHealth Group were worth $16,956,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group in the 1st quarter worth approximately $42,000. Finally, Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $41,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock traded up $5.59 during trading on Friday, reaching $250.26. The company's stock had a trading volume of 7,705,779 shares, compared to its average volume of 12,086,206. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $227.02 billion, a P/E ratio of 10.83, a price-to-earnings-growth ratio of 1.59 and a beta of 0.43. The company's fifty day moving average is $292.78 and its 200-day moving average is $408.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 EPS. The company's quarterly revenue was up 12.9% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. UnitedHealth Group's payout ratio is currently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a report on Monday. Wolfe Research decreased their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday. HSBC reiterated a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, Truist Financial decreased their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $366.52.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines